XENICAL For Professionals For Consumers
SearchSitemapContact Us
References

1. Allison DB, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538.

2.

Andres R. Mortality and obesity: the rationale for age-specific height-weight tables. In: Hazzard WR, Andres R, Bierman EL, Blass JP, eds. Principles of Geriatric Medicine and Gerontology. 2nd ed. New York, New York: McGraw-Hill; 1990;759-765.

3.

Astrup A, et al. The role of low-fat diets and fat substitutes in body weight management: what have we learned from clinical studies? J Am Diet Assoc. 1997;97(7 suppl):S82-S87.

4.

Beers, MH, Berkow R. Obesity: the excessive accumulation of body fat. The Merck Manual of Diagnosis & Therapy [Merck Web site]. Whitehouse Station, New Jersey: Merck & Co., Inc, 1999. Available at: http://www.merck.com/pubs/mmanual/section1/chapter5/5a.htm. Accessed Nov 12, 2000.

5.

Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3(suppl 2):211s-6s.

6.

Bonham GS, Brock DB. The relationship of diabetes with race, sex, and obesity. Am J Clin Nutr. 1985;41:776-783.

7.

Bray GA. Complications of obesity. Ann Intern Med. 1985;103(6 pt 2):1052-1062.

8.

Bray GA. Obesity. In: Fauci AS, et al., eds. Harrison's Principles of Internal Medicine. 14th ed. New York, New York: McGraw-Hill; 1998:454-462.

9.

Brown SL, et al. Motivational strategies used by dietitians to counsel individuals with diabetes. Diabetes Educator. 1998;24:313-318.

10.

Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: review of the research. Ann Behav Med. 1997;19:239-263.

11.

Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med. 2000;9:57-64.

12.

Chan JM, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-969.

13.

Chan S, Blackburn GL. Helping patients reverse the health risks of obesity. JCOM. 1997;4:37-51.

14.

Colditz GA, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.

15.

Data on file (Ref. 038-001), Genentech USA, Inc., South San Francisco, CA 94080-4990.

16.

Data on file (Ref. 038-014), Genentech USA, Inc., South San Francisco, CA 94080-4990.

17.

Data on file (Ref. 038-024), Genentech USA, Inc., South San Francisco, CA 94080-4990.

18.

Data on file (Ref. 038-041), Genentech USA, Inc., South San Francisco, CA 94080-4990.

19.

Data on file (Ref. 038-046), Genentech USA, Inc., South San Francisco, CA 94080-4990.

20.

Davidson MH, et al. Weight and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA. 1999;281:235-242.

21.

Després JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 1993;9:452-459.

22.

Després JP, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol. 1994;5:274-289.

23.

Després JP. Visceral obesity: a component of the insulin resistance dyslipidemic syndrome. Can J Cardiol. 1994;10(suppl B):17B-22B.

24.

Flier JS. Obesity. In: Kahn RC, Weir GC, eds. Joslin's Diabetes Mellitus. 13th ed. Philadelphia, Pennsylvania: Lea & Febiger; 1994:351-361.

25.

Freis ED. Improving treatment effectiveness in hypertension. Arch Intern Med. 1999;159:2517-2521.

26.

Galuska DA, et al. Are health care professionals advising obese patients to lose weight? JAMA. 1999;282:1576-1578.

27.

Havlik RJ, et al. Weight and hypertension. Ann Intern Med. 1983;98(pt 2):855-859.

28.

Hollander PA, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care. 1998;21:1288-1294.

29.

Hunt LM, Valenzuela MA, Pugh JA. Porque me toco a mi? Mexican American diabetes patients' causal stories and their relationship to treatment behaviors. Soc Sci Med. 1998;46:959-969.

30.

Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight-Management Programs. Washington, DC: National Academy Press; 1995.

31.

Jeffery RW, et al. A randomized trial of counseling for fat restriction versus calorie restriction in the treatment of obesity. Int J Obes Relat Metab Disord. 1995;19:132-137.

32.

Kanaley JA, et al. Differential health benefits of weight loss in upper-body and lower-body obese women. Am J Clin Nutr. 1993;57:20-26.

33.

Kannel WB, D'Agostino RB, Cobb JL. Effect of weight on cardiovascular disease. Am J Clin Nutr. 1996;63(suppl):419S-422S.

34.

Kaul L, Nidiry JJ. Management of obesity in low-income African Americans. J Natl Med Assoc. 1999;91:139-143.

35.

Kuczmarski RJ, et al. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205-211.

36.

Lenfant C, Ernest N. National Heart, Lung, and Blood Institute, National Institutes of Health, Div of Health Examination Statistics, National Center for Health Statistics, CDC. Daily dietary fat and total food-energy intakes - Third National Health and Nutrition Examination Survey, phase 1,1988-1991 Morbidity and Mortality Weekly Report. 1994;43:16-7,123-125.

37.

Metz JA, et al. Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr. 1997;66:421-422.

38.

Mokhad AH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999;282:1519-1522.

39.

Must A, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-1529.

40.

National Committee for Quality Assurance. NCQA's State of Managed Care Quality Report. Washington, DC: NCQA; 2000.

41.

National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res. 1998;6(suppl 2):51S-209S.

42.

North American Association for the Study of Obesity. Guidelines for the approval and use of drugs to treat obesity. Obes Res. 1995;3:473-478.

43.

Oka M, Chaboyer W. Dietary behaviors and sources of support in hemodialysis patients. Clin Nurs Res. 1999;8:302-314.

44.

Ornish D, et al. Can lifestyle changes reverse coronary heart disease? Lancet. 1990;336:129-133.

45.

Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119(7 pt 2):655-660.

46.

Pi-Sunyer FX. Obesity. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia, Pennsylvania: WB Saunders Co; 1996:1161-1168.

47.

Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther. 1996;18:1006-1035, (discussion) 1005.

48.

Pi-Sunyer FX. Short-term medical benefits and adverse effects of weight loss. Ann Intern Med. 1993;119(7 pt 2):722-726.

49.

Quesenberry CP Jr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466-472.

50.

Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337:396-407.

51.

Schlundt DG, et al. Randomized evaluation of a low fat ad libitum carbohydrate diet for weight reduction. Int J Obes. 1993;17:623-629.

52.

Schoenberg NE, Amey CH, Coward RT. Stories of meaning: lay perspectives on the origin and management of non-insulin dependent diabetes mellitus among older women in the United States. Soc Sci Med. 1998;47:2113-2125.

53.

Shah M, et al. Comparison of a low-fat, ad libitum complex-carbohydrate diet with a low-energy diet in moderately obese women. Am J Clin Nutr. 1994;59:980-984.

54.

Shape Up America and the American Obesity Association. Guidance for Treatment of Adult Obesity. Bethesda, Maryland: Shape Up America; 1996.

55.

Sherwin RS. Diabetes mellitus. In: Bennett JC, Plum F. Cecil Textbook of Medicine. 20th ed. Philadelphia, Pennsylvania: WB Saunders Co; 1996:1258-1277.

56.

Siggaard R, Raben A, Astrup A. Weight loss during 12 weeks' ad libitum carbohydrate-rich diet in overweight and normal-weight subjects at a Danish work site. Obes Res. 1996;4:347-356.

57.

Sjostrom L, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352:167-173.

58.

Society of Actuaries and Association of Life Insurance Medical Directors of America. Build Study. 1979; March 1980.

59.

Stunkard AJ. Current views on obesity. Am J Med. 1996;100:230-236.

60.

Susman JL, Helseth LD. Reducing the complications of type II diabetes: A patient-centered approach. Am Fam Physician. 1997;56:471-480.

61.

Toubro S, Astrup A. Randomized comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake. BMJ. 1997;314(7073):29-34.

62.

Travis T. Patient perceptions of factors that affect adherence to dietary regimens for diabetes mellitus. Diabetes Educator. 1997;23:152-156.

63.

US Department of Health and Human Services, Public Health Services. Update: prevalence of overweight among children, adolescents, and adults-United States, 1988-1994. Morbidity and Mortality Weekly Report. 1997;46:199-202.

64.

van der Kooy K, et al. Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr. 1993;57:327-333.

65.

Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985;103(6 pt 2):983-988.

66.

Williamson AR, et al. Recommendations of dietitians for overcoming barriers to dietary adherence in individuals with diabetes. Diabetes Educator. 2000;26:272-279.

67.

Windhauser MM, et al. Dietary adherence in the Dietary Approaches to Stop Hypertension Trial. J Am Diet Assoc. 1999;99(8 suppl):S76-S83.

68.

Wing RR, Jeffery RW. Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. J Consult Clin Psychol. 1999;67:132-138.

69.

Witteman JCM, et al. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989;80:1320-1327.

70.

Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6:97-106.

71.

Wolf AM, Colditz GA. Social and economic effects of body weight in the United States. Am J Clin Nutr. 1996;63(suppl):466S-469S.

72.

World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation of Obesity. Geneva, Switzerland: World Health Organization; 1997.